Oncology RSS Feeds

Directory1 oncology feeds · 25 articlesShow all languages →

Latest

Oncology articles

Daraxonrasib drug nearly doubles survival in advanced pancreatic cancer, oncologist reports

Pancreatic cancer has extremely low survival rates (97% mortality within 5 years for metastatic cases) due to lack of effective screening and late symptom onset. The article discusses daraxonrasib, a breakthrough drug that nearly doubles survival for advanced pancreatic cancer pa

Insightsciencehealthmedical research

news.cuanschutz.edu·Tech by Flipboard·1d ago·4 min read

Targeting genomic instability: From chemotherapy to precision medicine in cancer treatment

Insightsciencehealthoncology

Shared by @shihcheng.bsky.social ↗

cell.com3d ago

Sugar shields help immune cells infiltrate tumors' hostile microenvironment to fight cancer

Insightsciencehealthimmunotherapy

Shared by @us.theconversation.com ↗

theconversation.com3d ago

Experimental Drug Daraxonrasib Shows First Major Survival Benefit for Pancreatic Cancer Patients

Newssciencehealthmedical breakthrough

Shared by @billschuttauthor.bsky.social ↗

nytimes.com3d ago

Toxic Metals as Emerging Risk Factors for Hormone-Related Reproductive Cancers

Insightsciencehealthenvironmental health

Shared by @gracefuluniverse.bsky.social ↗

onlinelibrary.wiley.com5d ago

�

Depression affects one-third of cancer patients yet remains largely untreated in oncology care

Newssciencemental healthhealth

Shared by @nbcnews.com ↗

nbcnews.to7d ago

Oxford and Moderna receive approval for Phase 1 trial of mRNA vaccine to prevent Lynch syndrome cancers

Newssciencehealthmedical research

Shared by @oxfordcancer.bsky.social ↗

cancer.ox.ac.uk7d ago

Blood Proteins Could Predict Lung Cancer Years Before Diagnosis, Early Research Shows

An international team of over 80 researchers across four continents has identified blood proteins that can predict lung cancer more than five years before diagnosis. The study also found early evidence that an existing anti-inflammatory drug could significantly reduce lung cancer

Newssciencehealthmedical research

nytimes.com·Science·10d ago·2 min read

New Drug Shows Promise in Penetrating Pancreatic Cancer's 'Fibrotic Fortress'

Pancreatic cancer has an extremely low survival rate (97% mortality within 5 years for metastatic cases) due to late detection and the formation of a 'fibrotic fortress' that shields tumors from chemotherapy. The article discusses a potential breakthrough drug that has achieved w

Newssciencehealthmedical breakthrough

sciencealert.com·Tech by Flipboard·7d ago·6 min read

Experimental pill daraxonrasib nearly doubles survival time for advanced pancreatic cancer patients

Researchers reported that daraxonrasib, a novel daily pill, helped people with advanced pancreatic cancer live longer by blocking a mutated protein that fuels tumor growth in over 90% of cases. The drug nearly doubled survival time, marking a significant step forward in treating

Newssciencehealthmedical research

abcnews.com·Tech by Flipboard·14d ago·5 min read

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

Newssciencehealthmedical research

Shared by @chicagotribune.com ↗

chicagotribune.com16d ago

Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial

Newssciencehealthbiotechnology

Shared by @sgvtribune.bsky.social ↗

pasadenastarnews.com16d ago

International trial shows DNA test could help many breast cancer patients avoid chemotherapy

Newssciencehealthmedical research

Shared by @davidbflower.bsky.social ↗

bbc.co.uk17d ago

Principles and guidance for developing lncRNA-targeted cancer therapies

Insightsciencehealthoncology

Shared by @shihcheng.bsky.social ↗

doi.org17d ago

CancerNetwork1

Daraxonrasib drug nearly doubles survival in advanced pancreatic cancer, oncologist reports

Targeting genomic instability: From chemotherapy to precision medicine in cancer treatment

Sugar shields help immune cells infiltrate tumors' hostile microenvironment to fight cancer

Experimental Drug Daraxonrasib Shows First Major Survival Benefit for Pancreatic Cancer Patients

Toxic Metals as Emerging Risk Factors for Hormone-Related Reproductive Cancers

Depression affects one-third of cancer patients yet remains largely untreated in oncology care

Oxford and Moderna receive approval for Phase 1 trial of mRNA vaccine to prevent Lynch syndrome cancers

Blood Proteins Could Predict Lung Cancer Years Before Diagnosis, Early Research Shows

New Drug Shows Promise in Penetrating Pancreatic Cancer's 'Fibrotic Fortress'

Experimental pill daraxonrasib nearly doubles survival time for advanced pancreatic cancer patients

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial

International trial shows DNA test could help many breast cancer patients avoid chemotherapy

Principles and guidance for developing lncRNA-targeted cancer therapies